Bringing science and development together through news and analysis

Open data key to tackling neglected tropical diseases
  • Open data key to tackling neglected tropical diseases

Copyright: Andrew McConnell/Panos

Speed read

  • About one billion people globally suffer from neglected tropical diseases (NTDs)

  • Experts say open data could encourage collaboration among NTDs researchers

  • It could also spur discovery as researchers share positive and negative results

Shares
[CAPE TOWN] Open data access could promote collaborations among researchers in Africa and help in the fight against malaria, tuberculosis (TB) and neglected tropical diseases such as sleeping sickness, also called African trypanosomiasis.
 
At a time when demand for open data in health and drug discovery is dominating the digital space, some researchers say the model could work for Africa and alleviate the sufferings of many from these diseases.

“The amount of resources going into drug discovery for African neglected diseases by Africa in Africa is small. Open [source] can make an impact by supporting best practices and the best chances of results.”

Tim Wells, Medicines for Malaria Venture

 
Following the call on 23 April this year from the WHO for the disclosure of all results from clinical trials of new medicines, there is a push towards greater transparency.
 
Open access presents opportunities for African research and international collaboration, according to Michelle Willmers, project manager of Open Data Africa Initiative, University of Cape Town, South Africa.
 
“Open data initiatives provide local researchers with more avenues to get involved in what previously may have been considered high-level, niche or expensive drug discovery research,” says Willmers tells SciDev.Net in an exclusive interview.
 
Tim Wells, chief scientific officer of Switzerland-based Medicines for Malaria Venture, one of the funders of Open Source Malaria (OSM), says the initiative promotes the discovery of treatments against malaria through access to an open database of resources that lack patents. Users are encouraged to share data and ideas back into the domain.
 
“The amount of resources going into drug discovery for African neglected diseases by Africa in Africa is small. Open [source] can make an impact by supporting best practices and the best chances of results,” Wells adds.
 
Daniela Bagozzi, a WHO senior information manager, tells SciDev.Net: “The principle of data sharing is not new; it's one of the tenets of medical research and it allows for better knowledge shared across the scientific community so that decisions on medical products and public health spending can be made on the basis of sound knowledge.”
 
Matt Todd, a senior lecturer at the University of Sydney in Australia and leader of OSM, agrees: “We can share positive and negative outcomes, overcome the unproductive duplication of work and learn from experts around the world.”
 
Todd is also developing Open Source TB under the same tenets as OSM.
 
Neglected diseases affect over one billion people globally, according to WHO, with many of the diseases common in Africa. However, they are often overlooked by drug companies, which cannot recover the cost of developing and producing treatments.
But the open data movement has received support from some pharmaceutical companies. For instance, through an open database, the GlaxoSmithKline Open Lab initiative has made available nearly two million compounds known to have activity against the malaria parasite Plasmodium falciparum.
 
Building on the Open Lab data from GSK, Michael Pollastri, a professor of chemistry at Northeastern University in Massachusetts, United States, has created an open source model that has nearly 800 chemical compounds that could lead to drug treatments for African sleeping sickness.
 
“This is the largest set of published compounds tested against African sleeping sickness to date, and represents a strong starting point for drug discovery,” he says.
 
This article has been produced by SciDev.Net's Sub-Saharan Africa desk.
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.